Contact the Thymosin alpha-1 review board

Editorial contact

Reviews / Thymosin Alpha-1 is an editorial project. The most useful messages we receive are corrections — a citation that should be added, a quantitative figure that needs updating, a trial that has been retracted, an indication where the literature has moved. We read every note and update the board accordingly.

The contact form below accepts a short message and an optional citation reference. We do not respond to requests for personal medical advice — no member of the editorial team is a clinician, and personal medical questions belong with a treating physician rather than with an editorial publisher.

What we cannot help with

We cannot recommend a dose, route, or schedule for any individual. We cannot evaluate the safety of Thymosin alpha-1 use in a specific clinical context. We cannot recommend a vendor or a source. We do not sell, ship, or distribute Thymosin alpha-1 in any form. Questions of that nature are outside the editorial scope of this publication.

Editorial corrections

If a citation on this site is wrong — a wrong DOI, a misattributed author list, a misread effect size — please tell us. The board is meant to be erased and rewritten when the literature corrects itself, and we maintain a change-log of substantive edits. Every PMID and DOI on this site has been verified against the NCBI E-utilities esummary endpoint and the Crossref API; corrections to those identifiers are especially welcome.